JPH1054831A - Immunological analyzer - Google Patents
Immunological analyzerInfo
- Publication number
- JPH1054831A JPH1054831A JP16617797A JP16617797A JPH1054831A JP H1054831 A JPH1054831 A JP H1054831A JP 16617797 A JP16617797 A JP 16617797A JP 16617797 A JP16617797 A JP 16617797A JP H1054831 A JPH1054831 A JP H1054831A
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- reaction
- antibody
- analysis
- reaction section
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000001900 immune effect Effects 0.000 title claims abstract description 10
- 239000000427 antigen Substances 0.000 claims abstract description 31
- 102000036639 antigens Human genes 0.000 claims abstract description 29
- 108091007433 antigens Proteins 0.000 claims abstract description 29
- 238000004458 analytical method Methods 0.000 claims abstract description 28
- 239000002245 particle Substances 0.000 claims abstract description 27
- 239000000969 carrier Substances 0.000 claims abstract description 7
- 239000007788 liquid Substances 0.000 claims abstract 3
- 239000000126 substance Substances 0.000 claims description 19
- 238000002372 labelling Methods 0.000 claims description 12
- 239000011259 mixed solution Substances 0.000 claims description 12
- 238000012545 processing Methods 0.000 claims description 6
- 238000001514 detection method Methods 0.000 claims description 4
- 230000001678 irradiating effect Effects 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 238000005259 measurement Methods 0.000 abstract description 7
- 239000007790 solid phase Substances 0.000 abstract description 7
- 239000000463 material Substances 0.000 abstract description 3
- 239000012295 chemical reaction liquid Substances 0.000 abstract 1
- 239000006185 dispersion Substances 0.000 abstract 1
- 238000005194 fractionation Methods 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 239000004816 latex Substances 0.000 description 19
- 229920000126 latex Polymers 0.000 description 19
- 210000004027 cell Anatomy 0.000 description 13
- 238000000926 separation method Methods 0.000 description 13
- 239000000243 solution Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 8
- 238000010586 diagram Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 239000000592 Artificial Cell Substances 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- -1 etc. Substances 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 229940127121 immunoconjugate Drugs 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
Landscapes
- Automatic Analysis And Handling Materials Therefor (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、サンプル中の抗原
または抗体と反応する抗体または抗原を固相化した担体
を用いた免疫学的分析装置に関するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an immunological analyzer using a carrier on which an antibody or an antigen reacting with an antigen or an antibody in a sample is immobilized.
【0002】[0002]
【従来の技術】血液、体液等に含まれるグロブリン、酵
素等の蛋白質、ホルモン、細菌、ウイルス等はその分子
構造が類似していたり、ごく微量であるために、通常の
分析方法を用いた分析装置では同定、定量が困難であ
る。そこで、これらの物質の分析には、抗原または抗体
を粒子状の担体に固相化して抗原抗体反応を起こすよう
にした免疫学的な分析方法が一般に用いられている。2. Description of the Related Art Proteins such as globulin and enzymes contained in blood, body fluids, etc., hormones, bacteria, viruses, etc. have similar molecular structures or very small amounts. Identification and quantification are difficult with the device. Therefore, in the analysis of these substances, an immunological analysis method in which an antigen or an antibody is immobilized on a particulate carrier to cause an antigen-antibody reaction is generally used.
【0003】免疫学的分析方法には、例えば、標識物質
を用いるものとして、RIA(ラジオイムノアッセ
イ)、EIA(エンザイムイムノアッセイ)、FIA
(フルオロイムノアッセイ)等がある。また、これらの
標識物質を用いる分析方法は、測定系において、例えば
標識物質で標識した抗体(抗原)とサンプル中の抗原
(抗体)とが抗原抗体反応を起こした免疫複合体(Bou
nd)と、抗原抗体反応に関与せず、自由(Free )な状
態で残余する未反応成分としての標識抗体(抗原)とを
分離する操作、いわゆるB−F分離を必要とするヘテロ
ジニアス法と、必要としないホモジニアス法とに分類さ
れる。[0003] In an immunological analysis method, for example, RIA (radioimmunoassay), EIA (enzyme immunoassay), FIA
(Fluoroimmunoassay). In an analysis method using these labeling substances, in an assay system, for example, an immunocomplex (Bou) in which an antibody (antigen) labeled with a labeling substance and an antigen (antibody) in a sample cause an antigen-antibody reaction.
nd) and an operation of separating a labeled antibody (antigen) as an unreacted component remaining in a free state without being involved in the antigen-antibody reaction, that is, a heterogeneous method requiring so-called BF separation. , Which do not require a homogeneous method.
【0004】上記のヘテロジニアス法による分析方法と
しては、特開昭53-10495号公報において、カラムクロマ
トグラフィーを利用してB−F分離を行うようにしたも
のが提案されている。これは、例えば溶液中の遊離物質
(Free )を選択的に吸着し、免疫複合体(Bound)を
吸着しないイオン交換樹脂や、分子ふるい効果を有する
ゲルクロマトグラフィー用の充填剤を吸着剤として用い
て、所要の反応時間後にサンプルを含む遊離成分を未反
応成分として、B−F分離するというものである。As an analysis method by the above-mentioned heterogeneous method, Japanese Patent Application Laid-Open No. 53-10495 proposes a method in which BF separation is carried out by using column chromatography. For example, an ion exchange resin that selectively adsorbs free substances (Free) in a solution and does not adsorb an immune complex (Bound) or a packing material for gel chromatography having a molecular sieving effect is used as an adsorbent. Then, after a required reaction time, a free component containing a sample is subjected to BF separation as an unreacted component.
【0005】[0005]
【発明が解決しようとする課題】しかし、このようにB
−F分離にカラムクロマトグラフィーを用いて行うもの
において、多項目の分析を行うとすると、項目毎にカラ
ムを作成しなければならないと共に、反応液を項目毎に
異なるカラムに吸着させる操作が必要となる。したがっ
て、反応液の所要量が増すと共に、分析操作が煩雑にな
ってしまう。また、各カラムにおいて免疫複合体の大き
さや形状にばらつきがあったり、免疫複合体と遊離物質
との大きさが近接していると、B−F分離自体が困難と
なって精度が悪くなるとともに、B−F分離によってそ
れ以降の反応が起こらなくなるので、サンプルを効率良
く利用できない。しかも、例えば免疫グロブリン等の試
薬として用いる抗体と同じ分子や、化学的、物理的に類
似した分子の測定には使用できず、分析項目が極めて制
限される。However, as described above, B
In the case where a multi-item analysis is performed in a column chromatography using column chromatography for -F separation, a column must be created for each item, and an operation of adsorbing the reaction solution to a different column for each item is required. Become. Therefore, the required amount of the reaction solution increases, and the analysis operation becomes complicated. In addition, if the size or shape of the immune complex varies in each column, or if the size of the immune complex and the size of the free substance are close to each other, the BF separation itself becomes difficult and the accuracy becomes worse. , BF separation prevents the subsequent reaction from occurring, so that the sample cannot be used efficiently. Moreover, it cannot be used to measure the same molecule as an antibody used as a reagent such as immunoglobulin, or a molecule chemically or physically similar, and analysis items are extremely limited.
【0006】一方、特開昭52-15815号公報に記載された
技術は、複数異なる粒径の担体を用いて2回のB−F分
離工程後に、緩衝液中に懸濁させた担体をフローセルに
導入し、さらにレーザ光によって発生させた蛍光を検出
している。しかし、この技術は、B−F分離のための遠
心分離機を要するので、構成が複雑で且つ分析全体にか
かる時間が非常に長くなる上に、2回のB−F分離工程
の前には夫々充分で過剰量のサンプルと標識抗体とを反
応させる必要があるので分析効率が悪い。On the other hand, the technique described in Japanese Patent Application Laid-Open No. 52-15815 discloses a method in which a carrier suspended in a buffer is subjected to a flow cell after two BF separation steps using a plurality of carriers having different particle sizes. And the fluorescence generated by the laser light is detected. However, since this technique requires a centrifuge for BF separation, the structure is complicated and the time required for the whole analysis is very long, and furthermore, before the two BF separation steps, Since it is necessary to react a sufficient and excessive amount of the sample with the labeled antibody, the analysis efficiency is low.
【0007】本発明の目的は、上述した不具合を解決
し、免疫複合体の大きさや形状にばらつきがあっても高
精度に測定できると共に、多項目の分析を短時間で実施
できる免疫学的分析装置を提供しようとするものであ
る。SUMMARY OF THE INVENTION An object of the present invention is to solve the above-mentioned disadvantages and to carry out high-precision measurement even if the size or shape of the immune complex varies, and to carry out a multi-item analysis in a short time. It is intended to provide a device.
【0008】[0008]
【課題を解決するための手段】請求項1に係る本発明
は、サンプルと分析項目に対応する抗原または抗体を固
相化した多数の担体とを含む混合液を得て反応させるた
めの反応部と、前記反応部で混合後の混合液を前記反応
部から採取しフロ−サイトメータのニードル中に導入す
るためのサンプラと、フロ−セル内を流れる混合液に対
してレ−ザ光を照射してその受光デ−タを得る検出部
と、受光デ−タを粒径で表現される個別デ−タに分別し
粒径毎のデ−タ総量を求めるデ−タ処理部とを有するこ
とを特徴とする。According to a first aspect of the present invention, there is provided a reaction section for obtaining and reacting a mixed solution containing a sample and a number of carriers on which an antigen or an antibody corresponding to an analysis item is immobilized. A sampler for collecting the mixed solution mixed in the reaction section from the reaction section and introducing it into the needle of the flow cytometer; and irradiating the mixed solution flowing in the flow cell with laser light. And a data processing unit for separating the received light data into individual data represented by particle diameters and obtaining a total amount of data for each particle diameter. It is characterized by.
【0009】また、請求項2に係る本発明は、サンプル
と分析項目に対応する抗原または抗体を所定の標識物質
で標識した標識抗原または標識抗体と、分析項目に対応
する抗原または抗体を固相化した多数の担体とを含む混
合液を同時または逐次に得て反応させるための反応部
と、前記反応部で混合後の混合液を前記反応部から採取
しフロ−サイトメータのニードル中に導入するためのサ
ンプラと、フロ−セル内を流れる混合液から粒径に関す
る情報と標識物質に関する情報を示す受光デ−タを得る
検出部と、受光デ−タを粒径で表現される個別デ−タに
分別し粒径毎の標識物質量を求めるデ−タ処理部とを有
することを特徴とする。Further, the present invention according to claim 2 provides a sample and a labeled antigen or antibody obtained by labeling an antigen or an antibody corresponding to an analysis item with a predetermined labeling substance, and an antigen or an antibody corresponding to the analysis item on a solid phase. A reaction section for simultaneously or sequentially obtaining and reacting a mixed solution containing a large number of carriers that have been converted, and a mixed solution mixed in the reaction section is collected from the reaction section and introduced into a needle of a flow cytometer. A detector for obtaining information on the particle diameter and information on the labeling substance from the mixture flowing in the flow cell, and individual data expressed by the particle diameter. And a data processing unit for determining the amount of labeling substance for each particle size by separating the particles into data.
【0010】請求項2に係る発明の標識物質は、レ−ザ
光によって蛍光を発生する物質であり、検出部は、レ−
ザ光を照射する手段と共通のレーザ光から散乱光と蛍光
とをそれぞれ受光する手段とを具備することを特徴とす
る。[0010] The labeling substance of the invention according to claim 2 is a substance which emits fluorescence by laser light, and the detecting section comprises a laser.
And a means for irradiating the light and a means for respectively receiving scattered light and fluorescence from the common laser light.
【0011】[0011]
【発明の実施の形態】図1は本発明の分析装置における
反応模式図の一実施形態を示すものである。本形態にお
いて、符号1,2および3はそれぞれ担体に用いるポリ
スチレン製のラテックスで粒径は例えばラテックス1が
0.5μm、ラテックス2が 1.0μm、ラテックス3が
1.5μmというように、各径で均一なものを用いる。符
号4,5および6は各径のラテックス1,2および3に
それぞれ物理的吸着により固相化した固相抗体である。
また、符号7,8および9はサンプルである血清等に含
まれている抗原で、符号10,11および12はそれぞ
れの抗原7,8および9に特異的に結合する抗体をFI
TC等の蛍光物質で標識した標識抗体である。DESCRIPTION OF THE PREFERRED EMBODIMENTS FIG. 1 shows an embodiment of a schematic reaction diagram in an analyzer according to the present invention. In the present embodiment, reference numerals 1, 2 and 3 each represent a polystyrene latex used as a carrier, and the particle size is, for example, latex 1
0.5 μm, latex 2 1.0 μm, latex 3
One having a uniform diameter of 1.5 μm is used. Reference numerals 4, 5, and 6 denote solid phase antibodies immobilized on latexes 1, 2, and 3, respectively, having different diameters by physical adsorption.
Reference numerals 7, 8 and 9 denote antigens contained in the sample serum or the like, and reference numerals 10, 11 and 12 denote antibodies specifically binding to the respective antigens 7, 8 and 9 by FI.
It is a labeled antibody labeled with a fluorescent substance such as TC.
【0012】以下、ヒト免疫グロブリンクラスの特異性
分析を例にとって説明する。粒径 0.5μmのラテックス
1には抗ヒトIgG抗体4を、粒径 1.0μmのラテックス
2には抗ヒトIgA抗体5を、粒径 1.5μmのラテックス
3には抗ヒトIgM抗体6をそれぞれ固相化する。なお、
これらの固相抗体には、ラテックス同志の非特異吸着を
なくす意味と、抗原との特異性を増強する意味で、モノ
クローナル抗体の使用が望ましい。反応は、反応用緩衝
液 200μlにこれらの抗体結合ラテックス溶液50μl
と、ヒトIgG7、IgA8、IgM9等の抗原が含まれたサ
ンプル10μlと、それぞれFITCで標識した抗ヒトIg
G抗体10、抗ヒトIgA抗体11、抗ヒトIgM抗体12
の混合溶液50μlとを添加して行わせる。ここで、標識
抗体10,11,12は非特異吸着を少なく、また反応
速度を高める目的でFabフラグメントを用いることが望
ましい。また、これらの試薬類は全て同時に添加して反
応液を得るようにしても良いし、また、共通のサンプル
に対して各種の固相抗体および標識抗体を逐次添加した
反応液を得るようにしても良い。Hereinafter, the analysis will be described by taking the specificity analysis of the human immunoglobulin class as an example. Anti-human IgG antibody 4 is applied to latex 1 having a particle size of 0.5 μm, anti-human IgA antibody 5 is applied to latex 2 having a particle size of 1.0 μm, and anti-human IgM antibody 6 is applied to latex 3 having a particle size of 1.5 μm. Become In addition,
It is desirable to use a monoclonal antibody for these solid phase antibodies in order to eliminate non-specific adsorption between latexes and to enhance specificity with the antigen. The reaction was performed by adding 50 μl of these antibody-bound latex solutions to 200 μl of reaction buffer.
And 10 μl of a sample containing antigens such as human IgG7, IgA8 and IgM9, and anti-human Ig each labeled with FITC.
G antibody 10, anti-human IgA antibody 11, anti-human IgM antibody 12
And a mixed solution of 50 μl. Here, it is desirable to use Fab fragments for the labeled antibodies 10, 11, and 12 in order to reduce non-specific adsorption and to increase the reaction rate. In addition, all of these reagents may be added at the same time to obtain a reaction solution, or a reaction solution may be obtained by sequentially adding various solid-phase antibodies and labeled antibodies to a common sample. Is also good.
【0013】ここで、例えば37℃、10分間反応させる
と、各固相抗体ラテックス−抗原−標識抗体の免疫複合
体(Bound)13,14,15と残余の標識抗体(Fre
e )16とが生成される。本形態では、このようにして
サンプルと試薬とを混合して反応させた反応液を採取し
て図2に示すようなフロ−サイトメ−タに導入すること
により、フロ−セル21内で反応液を流すことができ
る。When the reaction is carried out, for example, at 37 ° C. for 10 minutes, the immunoconjugates (Bounds) 13, 14, 15 of each solid-phase antibody latex-antigen-labeled antibody and the remaining labeled antibody (Freund)
e) 16 is generated. In this embodiment, the reaction solution obtained by mixing and reacting the sample and the reagent in this manner is collected and introduced into a flow cytometer as shown in FIG. Can flow.
【0014】フローサイトメータは既に知られているよ
うに、細胞の分析専用機であり、フローセル21中のニ
ードル22に反応液23を流し、レーザ光24をその流
れに照射して細胞から発する散乱光や蛍光を測定する。
通常、前方散乱光はレーザ入射光とほぼ水平に位置する
ディテクタ25で検知され、主に細胞サイズの測定に用
いられる。蛍光は、レーザ光24の入射角に対して垂直
方向に位置するディテクタ26で検知され、細胞表面の
蛍光物質等の測定に用いられる。レーザ光24は単一波
長であるため、使用できる蛍光色素に制限があるが、本
形態の分析装置において用いる蛍光色素FITCは波長
489nm近くの光を吸収して波長 515nmの蛍光を発するの
で、この場合は波長 488nmのArレーザを用いれば良
い。As is already known, the flow cytometer is a dedicated machine for analyzing cells, in which a reaction solution 23 is caused to flow through a needle 22 in a flow cell 21 and a laser beam 24 is irradiated on the flow to scatter the light from the cells. Measure light and fluorescence.
Normally, the forward scattered light is detected by the detector 25 positioned substantially horizontally with the laser incident light, and is mainly used for measuring the cell size. The fluorescence is detected by a detector 26 located in a direction perpendicular to the incident angle of the laser light 24, and is used for measuring a fluorescent substance or the like on the cell surface. Since the laser beam 24 has a single wavelength, there are limitations on the fluorescent dyes that can be used, but the fluorescent dye FITC used in the analyzer of the present embodiment has a wavelength of
Since it absorbs light near 489 nm and emits fluorescence with a wavelength of 515 nm, an Ar laser with a wavelength of 488 nm may be used in this case.
【0015】なお、フローサイトメータとしては、例え
ば米国特許4325706号明細書に記載のものが使用可能で
ある。このようにして、反応後の図1に示す免疫複合体
13,14,15と残余の標識抗体16とが混ざり合っ
た反応液23をニードル22からフローセル21中に導
入し、ニードル22中を流れる各免疫複合体と残余の標
識抗体等の各成分のレーザ光24による散乱光および蛍
光をディテクタ25および26でそれぞれ検知すれば、
ディテクタ25によって各免疫複合体の大きさが測定さ
れ、しかもその大きさは各ラテックスの径が1μm前後
であれば、せいぜい数nmの固体抗体−抗原−標識抗体
結合部は誤差範囲となるから、殆どラテックスの粒径に
依存する。また、同時にディテクタ26により、各ラテ
ックス上に乗った蛍光量/1ラテックスが測定され、こ
れら2つのパラメータに基づいて検出情報分別処理部2
9が図3に示すサイトグラムを出力する。なお、図3に
おいて縦軸は蛍光量を、横軸は粒子径を表す。As the flow cytometer, for example, the one described in US Pat. No. 4,325,706 can be used. In this manner, the reaction solution 23 in which the immune complexes 13, 14, 15 and the remaining labeled antibody 16 shown in FIG. 1 after the reaction are mixed is introduced from the needle 22 into the flow cell 21, and flows through the needle 22. If the scattered light and fluorescence of each immune complex and the remaining components such as the labeled antibody by the laser light 24 are detected by the detectors 25 and 26, respectively,
The size of each immune complex is measured by the detector 25, and if the size of each latex is about 1 μm, the solid antibody-antigen-labeled antibody binding portion of at most several nm is within the error range. Mostly dependent on latex particle size. At the same time, the amount of fluorescence on each latex / 1 latex is measured by the detector 26, and based on these two parameters, the detection information classification processing unit 2
9 outputs the cytogram shown in FIG. In FIG. 3, the vertical axis represents the amount of fluorescence, and the horizontal axis represents the particle diameter.
【0016】ここで、抗原抗体反応に関与しなかった残
余の標識抗体は微径であるから、1標識抗体あたりの蛍
光量の位置31に集中する。また、径が1番小さいラテ
ックスにより結合した図1の免疫複合体13は位置32
に、2番目に小さいラテックスにより結合した図1の免
疫複合体14は、抗原濃度が高かったのでラテックス1
個あたりの蛍光量としてもかなり高い位置33に示され
る。また、一番ラテックス径が大きかった図1の免疫複
合体15は、抗原濃度が薄かったので位置34に示され
ることになる。Here, since the remaining labeled antibody which has not been involved in the antigen-antibody reaction has a small diameter, it concentrates on the position 31 of the amount of fluorescence per one labeled antibody. In addition, the immune complex 13 of FIG.
In addition, the immune complex 14 of FIG. 1, bound by the second smallest latex,
It is shown at the position 33 which is considerably high also as the fluorescence amount per unit. The immune complex 15 of FIG. 1 having the largest latex diameter is shown at the position 34 because the antigen concentration was low.
【0017】このようにして蛍光量測定値が得られれ
ば、予めIgG,IgA,IgM等各抗原の既知濃度系列から
同様にして求めた蛍光強度と抗原濃度との関係を表す検
量線に基づいてサンプル中の各抗原濃度を求めることが
できる。When the measured value of the fluorescence amount is obtained in this manner, based on a calibration curve representing the relationship between the fluorescence intensity and the antigen concentration, which is similarly obtained in advance from a known concentration series of each antigen such as IgG, IgA, and IgM. The concentration of each antigen in the sample can be determined.
【0018】以上のように、フローサイトメータと、各
抗原に応じて異なる抗体を固相化したラテックスを用い
るラテックスイムノアッセイとを組み合わせたことによ
り、1台の分析装置で多項目の分析を高速かつ高精度に
実施できる。また、B−F分離に伴う反応量の制約が無
いため、10μl程度の少量のサンプルと反応させた大
量のラテックスに関する免疫複合体の大きさを、B−F
分離なしにレ−ザ光によりもれなく測定するので、正確
なデ−タを効率良く得られる。また、抗原の種類毎に粒
径が異なるラテックスを同時に用いるようにすれば抗原
別の識別が容易な表示も可能となる。As described above, the combination of the flow cytometer and the latex immunoassay using the latex in which different antibodies are immobilized according to each antigen is combined, so that a single analyzer can analyze many items at high speed. Can be performed with high accuracy. In addition, since there is no restriction on the reaction amount associated with the BF separation, the size of the immune complex with respect to a large amount of latex reacted with a small amount of a sample of about 10 μl is defined as BF
Since measurement is performed without separation by laser light without separation, accurate data can be obtained efficiently. In addition, if latexes having different particle diameters are used simultaneously for each type of antigen, it is possible to display information that can be easily identified for each antigen.
【0019】なお、本発明は上述した実施形態にのみ限
定されるものではなく、幾多の変更または変形が可能で
ある。例えば、担体はラテックスに限らず、分子量の均
一な人工細胞等、測定対象に応じて任意の形状や大きさ
のものを用いることができる。また、フローサイトメー
タにソーティング機能を付加して、測定後に免疫複合
体、残余の標識抗体をそれぞれ分離することもできる。
このようにすれば、残余の標識抗体を分離して取り出す
ことができるから、これを再使用することができる。更
に、フローサイトメータに反応装置27やオートサンプ
ラ28等を付加することによって自動測定を容易に行う
ことができる。この場合、フローサイトメータにおける
測定速度は約500 粒子/sec であるから、1つのサンプ
ルについて1×106 粒子を測定したとしても、3分前
後で高速に分析することができる。また、本発明は競合
法による分析にも有効に適用することができる。It should be noted that the present invention is not limited to the above-described embodiment, and that various changes and modifications are possible. For example, the carrier is not limited to latex, but may be of any shape or size depending on the object to be measured, such as artificial cells having a uniform molecular weight. In addition, a sorting function can be added to the flow cytometer to separate the immune complex and the remaining labeled antibody after measurement.
In this way, the remaining labeled antibody can be separated and taken out, and can be reused. Further, automatic measurement can be easily performed by adding a reaction device 27, an autosampler 28, and the like to the flow cytometer. In this case, since the measurement speed in the flow cytometer is about 500 particles / sec, even if 1 × 10 6 particles are measured for one sample, high-speed analysis can be performed in about 3 minutes. Further, the present invention can be effectively applied to analysis by a competition method.
【0020】さらに、上述したような構成によれば、一
般のフロ−サイトメ−タを用いた細胞分析のように、担
体同士が結合するような反応に関する分析についても実
施するように設定できる。また、標識物質も、免疫学的
分析において一般に知られているような化学発光用の物
質を用いてもよい。Further, according to the above-described configuration, it can be set so as to carry out an analysis relating to a reaction in which carriers are bound to each other, such as a cell analysis using a general flow cytometer. As the labeling substance, a substance for chemiluminescence as generally known in immunological analysis may be used.
【0021】[0021]
【発明の効果】本発明によれば、フロ−セル内を流れる
混合液中の免疫複合体をレ−ザ光によりもれなく測定し
てその個別デ−タを粒子径毎に総量でもって表示するの
で、免疫学的反応結果を短時間でかつ高精度に分析でき
る。しかも、反応部で反応させた混合液をサンプラによ
って採取してフローサイトメータのニードル中へ導入す
ることにより、フローセル内で流通させるだけの構成で
あるから、多数の分析を1台の自動化装置で効率良く分
析できる。According to the present invention, the immune complex in the mixture flowing in the flow cell is measured without any laser light, and the individual data is displayed as the total amount for each particle diameter. In addition, immunological reaction results can be analyzed in a short time and with high accuracy. In addition, since the mixed solution reacted in the reaction section is collected by a sampler and introduced into the needle of the flow cytometer, it is simply distributed in the flow cell, so that a large number of analyzes can be performed with a single automated device. Can be analyzed efficiently.
【図1】図1は本発明における一実施形態の反応模式図
である。FIG. 1 is a schematic reaction diagram of one embodiment of the present invention.
【図2】図2はフローサイトメータを説明するための図
である。FIG. 2 is a diagram for explaining a flow cytometer.
【図3】図3は測定データのサイトグラムを示す図であ
る。FIG. 3 is a diagram showing a cytogram of measurement data.
1,2,3 ラテックス 4,5,6 固相抗体 7,8,9 抗原 10,11,12 標識抗体 13,14,15 免疫複合体 16 残余の標識抗体 21 フローセル 22 ニードル 23 反応液 24 レーザ光 25,26 ディテクタ 27 反応装置 28 オートサンプラ 29 検出情報分別処理部 1,2,3 Latex 4,5,6 Solid-phase antibody 7,8,9 Antigen 10,11,12 Labeled antibody 13,14,15 Immune complex 16 Remaining labeled antibody 21 Flow cell 22 Needle 23 Reaction solution 24 Laser light 25, 26 Detector 27 Reactor 28 Autosampler 29 Detection information separation processing unit
Claims (3)
は抗体を固相化した多数の担体とを含む混合液を得て反
応させるための反応部と、前記反応部で混合後の混合液
を前記反応部から採取しフロ−サイトメータのニードル
中に導入するためのサンプラと、フロ−セル内を流れる
混合液に対してレ−ザ光を照射してその受光デ−タを得
る検出部と、受光デ−タを粒径で表現される個別デ−タ
に分別し粒径毎のデ−タ総量を求めるデ−タ処理部とを
有することを特徴とする免疫学的分析装置。1. A reaction section for obtaining and reacting a mixed solution containing a sample and a large number of carriers on which an antigen or an antibody corresponding to an analysis item is immobilized, and reacting the mixed solution mixed in the reaction section. A sampler for collecting from the reaction section and introducing it into the needle of the flow cytometer; a detection section for irradiating the mixed solution flowing in the flow cell with laser light to obtain the received light data; An immunological analyzer comprising: a data processing unit for separating received light data into individual data represented by a particle size and obtaining a total amount of data for each particle size.
は抗体を所定の標識物質で標識した標識抗原または標識
抗体と、分析項目に対応する抗原または抗体を固相化し
た多数の担体とを含む混合液を同時または逐次に得て反
応させるための反応部と、前記反応部で混合後の混合液
を前記反応部から採取しフロ−サイトメータのニードル
中に導入するためのサンプラと、フロ−セル内を流れる
混合液から粒径に関する情報と標識物質に関する情報を
示す受光デ−タを得る検出部と、受光デ−タを粒径で表
現される個別デ−タに分別し粒径毎の標識物質量を求め
るデ−タ処理部とを有することを特徴とする免疫学的分
析装置。2. A mixture comprising a sample and a labeled antigen or antibody obtained by labeling an antigen or antibody corresponding to an analysis item with a predetermined labeling substance, and a large number of carriers having the antigen or antibody corresponding to the analysis item immobilized thereon. A reaction section for obtaining and reacting liquids simultaneously or sequentially; a sampler for collecting a mixed solution mixed in the reaction section from the reaction section and introducing it into a needle of a flow cytometer; and a flow cell. A detection unit that obtains light-receiving data indicating information on the particle size and information on the labeling substance from the mixed solution flowing through the inside, and separates the light-receiving data into individual data expressed by the particle size to label each particle size An immunological analyzer, comprising: a data processing unit for determining an amount of a substance.
生する物質であり、検出部は、レ−ザ光を照射する手段
と共通のレーザ光から散乱光と蛍光とをそれぞれ受光す
る手段とを具備することを特徴とする請求項2記載の免
疫学的分析装置。3. The labeling substance is a substance that generates fluorescence by laser light, and the detecting unit receives scattered light and fluorescence from a laser beam common to the means for irradiating the laser light. The immunological analyzer according to claim 2, comprising:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16617797A JPH1054831A (en) | 1997-06-23 | 1997-06-23 | Immunological analyzer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16617797A JPH1054831A (en) | 1997-06-23 | 1997-06-23 | Immunological analyzer |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP8131602A Division JP2709296B2 (en) | 1996-05-27 | 1996-05-27 | Immunological analysis method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH1054831A true JPH1054831A (en) | 1998-02-24 |
Family
ID=15826514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP16617797A Pending JPH1054831A (en) | 1997-06-23 | 1997-06-23 | Immunological analyzer |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH1054831A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003019155A1 (en) * | 2001-08-27 | 2003-03-06 | Asahi Kasei Kabushiki Kaisha | Method of analyzing interaction between material and biological substance |
-
1997
- 1997-06-23 JP JP16617797A patent/JPH1054831A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003019155A1 (en) * | 2001-08-27 | 2003-03-06 | Asahi Kasei Kabushiki Kaisha | Method of analyzing interaction between material and biological substance |
| GB2395558A (en) * | 2001-08-27 | 2004-05-26 | Asahi Chemical Ind | Method of analyzing interaction between material and biological substance |
| GB2395558B (en) * | 2001-08-27 | 2005-03-23 | Asahi Chemical Ind | Method of analyzing interaction between material and biological substance |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0595641B1 (en) | One-step simultaneous immunoassay | |
| US5219763A (en) | Agglutination method for the determination of multiple ligands | |
| SE443660B (en) | PROCEDURE AND REAGENT FOR IMMUNAL ANALYSIS WITH RF OR CLQ ADSORBED TO FIXED BEARERS | |
| NL7907939A (en) | COMBINED HETEROGENE-SPECIFIC BINDING TESTS. | |
| JP4274944B2 (en) | Particle-based ligand assay with extended dynamic range | |
| KR920000056B1 (en) | Measuring method of specifically bindable substance | |
| JP3908272B2 (en) | Solid phase assay for detection of ligands | |
| KR101718485B1 (en) | Device for Detecting Colored Reaction or Fluorescence Reaction of Immunochromatography | |
| US4865997A (en) | Assay for ligands by separating bound and free tracer from sample | |
| JP2005510706A5 (en) | ||
| US4138213A (en) | Agglutination immunoassay of immune complex with RF or Clq | |
| JPH055741A (en) | Method for immunological quantitative analysis | |
| JP2004132892A (en) | Immunity chromatograph measurement method and kit therefor | |
| JP2709296B2 (en) | Immunological analysis method | |
| JPH1054831A (en) | Immunological analyzer | |
| CN116068183B (en) | An immunoassay method and its application | |
| US20050106564A1 (en) | One-step, no-wash multiplex bead-based flow cytometric assay | |
| US7851229B2 (en) | Two-phase optical assay with unitized container and double or single sensor systems | |
| JPS61110059A (en) | Immunological analysis | |
| JPH05215750A (en) | Immunological analysis method | |
| JPH0588423B2 (en) | ||
| CN114127559A (en) | Single-tube article for serology comprising a set of differently labeled cells | |
| JPS61132868A (en) | Immunological analysis | |
| JPS61132869A (en) | Immunological analysis | |
| JP4410374B2 (en) | Multi-item biological sample inspection method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 19981020 |